Literature DB >> 8989235

Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.

V R Agarwal1, C I Ashanullah, E R Simpson, S E Bulun.   

Abstract

Estrogen biosynthesis in adipose tissue has assumed great significance in terms of a number of estrogen-related diseases. The biosynthesis of estrogens from C19 steroids is catalyzed by a specific form of cytochrome P450, namely aromatase cytochrome P450 (P450arom; the product of the CYP19 gene). The human CYP19 gene comprises nine coding exons, II-X, and its transcripts are expressed in the ovary, placenta, testes, adipose tissue, and brain. Tissue-specific expression of the CYP19 gene is determined at least in part by the use of tissue-specific promoters, which give rise to transcripts with unique 5'-noncoding termini. Thus, the distal promoter I.1 is responsible for expression uniquely in placenta. On the other hand, the proximal promoter II, which regulates expression via a cAMP-dependent signaling pathway, is responsible for expression in the gonads. Transcripts in breast adipose tissue contain 5'-termini corresponding to expression derived from promoters I.4, II, and I.3, with I.4-specific termini predominating. The latter are derived from promoter I.4, which contains a glucocorticoid response element and an interferon-gamma activation site element and is responsible for expression in the presence of glucocorticoids and members of the class I cytokine family. The object of the present study was to determine the distribution of these various transcripts in adipose tissue from abdomen, buttocks, and thighs of women, as this would provide important clues to the factors regulating aromatase expression in these sites. To achieve this, we employed competitive reverse transcription-PCR to amplify unique 5'-ends of each of the transcripts of the CYP19 gene that are expressed in adipose tissue as well as for the coding region to evaluate total CYP19 gene (P450arom) transcript levels. We observed that exon I.4-specific transcripts were predominantly present in adipose tissue samples obtained from women regardless of the tissue site or the age of the individual. In these tissues, promoter II- and exon I.3-specific transcripts were present in lower copy numbers. We also demonstrated that in these sites total or exon-specific P450arom transcripts levels increased in direct proportion to advancing age and that transcript levels were the highest in buttocks, followed by thighs, and lowest in the abdomen. These results suggest that in normal human adipose tissue, aromatase expression is mainly under local control by a number of cytokines via paracrine and autocrine mechanisms in the presence of systemic glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989235     DOI: 10.1210/jcem.82.1.3655

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

Review 2.  Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.

Authors:  Priya Bhardwaj; CheukMan C Au; Alberto Benito-Martin; Heta Ladumor; Sofya Oshchepkova; Ruth Moges; Kristy A Brown
Journal:  J Steroid Biochem Mol Biol       Date:  2019-03-06       Impact factor: 4.292

Review 3.  Aromatase inhibitors for the treatment of endometriosis.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-09-19       Impact factor: 7.329

4.  Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.

Authors:  David Langoi; Mary Ellen Pavone; Bilgin Gurates; Daniel Chai; Asgerally Fazleabas; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-12-17       Impact factor: 7.329

Review 5.  Understanding and management of male breast cancer: a critical review.

Authors:  Kartikeya Pant; Udayan Dutta
Journal:  Med Oncol       Date:  2007-12-12       Impact factor: 3.064

6.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 7.  A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer.

Authors:  Hajar Ku Yasin; Anthony H Taylor; Thangesweran Ayakannu
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

8.  DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes.

Authors:  Joshua R Lewis; Tegan J McNab; Lawrence J Liew; Jeremy Tan; Phillip Hudson; Jenny Z Wang; Richard L Prince
Journal:  BMC Med Genet       Date:  2013-08-30       Impact factor: 2.103

9.  Effect of Letrozole on endometriosis-related pelvic pain.

Authors:  Fariba Almassinokiani; Alireza Almasi; Peyman Akbari; Mahboubeh Saberifard
Journal:  Med J Islam Repub Iran       Date:  2014-10-04

10.  A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue.

Authors:  Hong Zhao; Joy Innes; David C Brooks; Scott Reierstad; Mehmet B Yilmaz; Zhihong Lin; Serdar E Bulun
Journal:  Reprod Biol Endocrinol       Date:  2009-04-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.